Glaukos Future Growth
Future criteria checks 1/6
Glaukos is forecast to grow earnings and revenue by 57.1% and 19.5% per annum respectively. EPS is expected to grow by 55.3% per annum. Return on equity is forecast to be -9% in 3 years.
Key information
57.1%
Earnings growth rate
55.3%
EPS growth rate
Medical Equipment earnings growth | 18.3% |
Revenue growth rate | 19.5% |
Future return on equity | -9.0% |
Analyst coverage | Good |
Last updated | 06 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 558 | -29 | 61 | 167 | 10 |
12/31/2025 | 449 | -80 | -24 | 37 | 14 |
12/31/2024 | 363 | -128 | -48 | -27 | 14 |
3/31/2024 | 326 | -141 | -75 | -61 | N/A |
12/31/2023 | 315 | -135 | -78 | -58 | N/A |
9/30/2023 | 304 | -129 | -75 | -51 | N/A |
6/30/2023 | 297 | -126 | -97 | -70 | N/A |
3/31/2023 | 289 | -139 | -104 | -74 | N/A |
12/31/2022 | 283 | -99 | -63 | -33 | N/A |
9/30/2022 | 285 | -90 | -65 | -34 | N/A |
6/30/2022 | 288 | -56 | -25 | 11 | N/A |
3/31/2022 | 294 | -28 | -7 | 30 | N/A |
12/31/2021 | 294 | -50 | -23 | 25 | N/A |
9/30/2021 | 294 | -38 | -1 | 40 | N/A |
6/30/2021 | 284 | -60 | -19 | 13 | N/A |
3/31/2021 | 238 | -83 | -29 | -6 | N/A |
12/31/2020 | 225 | -120 | -30 | -23 | N/A |
9/30/2020 | 218 | -73 | -44 | -38 | N/A |
6/30/2020 | 211 | -71 | -37 | -31 | N/A |
3/31/2020 | 238 | -37 | -19 | -14 | N/A |
12/31/2019 | 237 | 15 | -5 | 0 | N/A |
9/30/2019 | 225 | -19 | 10 | 21 | N/A |
6/30/2019 | 211 | -12 | 17 | 28 | N/A |
3/31/2019 | 195 | -12 | 16 | 26 | N/A |
12/31/2018 | 181 | -13 | 9 | 19 | N/A |
9/30/2018 | 169 | -14 | 10 | 14 | N/A |
6/30/2018 | 165 | -6 | 11 | 17 | N/A |
3/31/2018 | 163 | -4 | 11 | 17 | N/A |
12/31/2017 | 159 | 0 | N/A | 26 | N/A |
9/30/2017 | 151 | -1 | N/A | 17 | N/A |
6/30/2017 | 140 | -1 | N/A | 14 | N/A |
3/31/2017 | 127 | 5 | N/A | 16 | N/A |
12/31/2016 | 114 | 5 | N/A | 12 | N/A |
9/30/2016 | 102 | 2 | N/A | 8 | N/A |
6/30/2016 | 91 | -1 | N/A | 4 | N/A |
3/31/2016 | 80 | -35 | N/A | -2 | N/A |
12/31/2015 | 72 | -37 | N/A | -2 | N/A |
9/30/2015 | 66 | -40 | N/A | -3 | N/A |
6/30/2015 | 59 | -39 | N/A | -2 | N/A |
3/31/2015 | 52 | -9 | N/A | -3 | N/A |
12/31/2014 | 46 | -12 | N/A | -7 | N/A |
9/30/2014 | 38 | -11 | N/A | -8 | N/A |
6/30/2014 | 33 | -12 | N/A | -10 | N/A |
3/31/2014 | 26 | -13 | N/A | -13 | N/A |
12/31/2013 | 21 | -13 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6GJ is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 6GJ is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 6GJ is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 6GJ's revenue (19.5% per year) is forecast to grow faster than the German market (5.1% per year).
High Growth Revenue: 6GJ's revenue (19.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 6GJ is forecast to be unprofitable in 3 years.